ArticleFrontiers in oncology2022

Case report: Pharmacokinetics of pembrolizumab in a patient with stage IV non-small cell lung cancer after a single 200 mg administration.

Fenna de Vries et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.